Services
Adaptive Design for Clinical Trials
Accelerate Clinical Development Success with Proven Expertise for Adaptive Clinical Trial Design, Simulation, and Execution
Adaptive design clinical trials are encouraged by the FDA to expedite and improve efficiencies for identifying the clinical benefit of new therapies. Compared to traditional clinical trial designs, adaptive clinical trial designs are more complex and therefore require careful consideration, rigorous planning, and trial simulations prior to clinical study start-up. But, adaptive designs offer many potential benefits such as increasing the trial's probability of success, reducing the overall time and cost of the trial, and delivering the right drug to the right patients.
Adaptive Design Clinical Trials
Veristat will provide you with the expertise in the strategic planning, design, optimization, and implementation of your adaptive design. To embark on an adaptive design trial requires the ability to plan and communicate the design to the regulatory agencies then to communicate and execute the study with the investigational sites and overall project team. This is where Veristat can help you. Our experts will:
- Utilize trial simulations to recommend various adaptive design options according to the disease area and company portfolio
- Develop the adaptive design protocol and outline the strategy for working with regulatory authorities
- Execute the adaptive design including trial monitoring, interim analysis, and suggesting necessary adaptations
- Provide analysis and interpretation of the adaptive trial data
Adaptive Design is: A clinical trial design that allows for prospectively planned modifications to one or more aspects of the design based on accumulating data from subjects in the trial.
FDA Guidance
November 2019
Adaptive Trials
Expertise from start to finish
PLAN
Establish adaptive trial goals and outline the strategy for working with regulatory authorities
DESIGN
Develop the adaptive design methodology and design the protocol accordingly
SIMULATE
Utilize trial simulations to recommend various adaptive design options according to the disease area and company portfolio
IMPLEMENT
Execute the adaptive design trial - inclusive of trial monitoring, interim analysis, and making necessary adaptations. Provide final analysis and interpretation of the trial data.
Planning, Simulating, and Implementing Both Simple and Complex Adaptive Clinical Trial Designs
Types of Adaptive Clinical Trial Designs |
|
---|---|
Adaptive Dose-Escalation Design (ADED) | Adaptive Dose Finding |
Adaptive Randomization Design | Dropping Treatment Arm (or Pick the Winner Design) |
Group Sequential Design (GSD) | Population Enrichment Design |
Sample Size Re-Estimation (SSR) | Seamless Phase I/II or II/III Design |
Benefits of Adaptive Clinical Trial Designs
- Reduces cost, time & required resources
- Increases the chance of a successful study via midcourse corrections
- Reduces time to market
- Mitigates risks
- Improves patient safety
- Facilitates better decision-making
Considerations for Adaptive Clinical Trial Designs
- Requires more intensive planning
- Commands more frequent interaction with regulatory agencies
- Improper execution can introduce bias
- Confounding can result from adaptations
- Certain adaptive designs may require larger sample sizes
- Statistical significance (alpha) penalties apply
When to Consider Adaptive Designs
While adaptive designs can be advantageous in certain circumstances, they are not suited for every clinical trial. Adaptive designs are highly encouraged for clinical trials in the following applications:
Oncology trials
Particularly in early phase dose-finding trial designs that use intermediate or accelerated approval endpoints for decision-making
Rare disease trials
Limited patient populations can use supplemental data from earlier run trials, disease progression analytical models, or previous adult trials
Trials with large cardiovascular risk
Used for safety monitoring to leverage controls patient from other sources